Cargando…

Beneficial Effects of Pulmonary Vasodilators on Pre-Capillary Pulmonary Hypertension in Patients with Chronic Kidney Disease on Hemodialysis

Background: In patients with chronic kidney disease (CKD) on hemodialysis, comorbid pulmonary hypertension (PH) aggravates exercise tolerance and eventually worsens the prognosis. The treatment strategy for pre-capillary PH, including combined pre- and post-capillary PH (Cpc-PH), has not been establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimuro, Keiji, Hosokawa, Kazuya, Abe, Kohtaro, Masaki, Kohei, Imakiire, Satomi, Sakamoto, Takafumi, Tsutsui, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224627/ https://www.ncbi.nlm.nih.gov/pubmed/35743811 http://dx.doi.org/10.3390/life12060780

Ejemplares similares

Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension
por: Watanabe, Takanori, et al.
Publicado: (2021)

Chronic Inhibition of Toll‐Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats
por: Ishikawa, Tomohito, et al.
Publicado: (2021)

A novel pulmonary circulation imaging using dynamic digital radiography for chronic thromboembolic pulmonary hypertension
por: Yamasaki, Yuzo, et al.
Publicado: (2020)

Visibility of Pulmonary Valve and Pulmonary Regurgitation on Intracardiac Echocardiography in Adult Patients with Tetralogy of Fallot
por: Sakamoto, Ichiro, et al.
Publicado: (2023)

Adenosine as pulmonary vasodilator in ARDS
por: Molina, JM, et al.
Publicado: (1998)

Pulmonary ventilation–perfusion mismatch demonstrated by dynamic chest radiography in giant cell arteritis
por: Yamasaki, Yuzo, et al.
Publicado: (2020)

Inhaled pulmonary vasodilators in refractory hypoxemia
por: Wright, Brian J.
Publicado: (2015)

Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome
por: Ohashi, Kana, et al.
Publicado: (2019)

Pulmonary vasodilation in acute pulmonary embolism – a systematic review
por: Lyhne, Mads Dam, et al.
Publicado: (2020)

Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension
por: Yoshida, Keimei, et al.
Publicado: (2018)

Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial
por: Hosokawa, Kazuya, et al.
Publicado: (2022)

Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
por: Morales-Cano, Daniel, et al.
Publicado: (2021)

Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease
por: Nakamura, Junichi, et al.
Publicado: (2022)

Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema
por: Kusaka, Kei, et al.
Publicado: (2019)

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2020)

Effects of Different Pulmonary Vasodilators on Arterial Saturation in a Model of Pulmonary Hypertension
por: Becker, Eva Maria, et al.
Publicado: (2013)

Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
por: Franco, Veronica, et al.
Publicado: (2020)

Pulmonary capillary pressure in pulmonary hypertension
por: Souza, Rogerio, et al.
Publicado: (2005)

It’s Time to Put the Term “Pulmonary Vasodilators” to Rest
por: Rubin, Lewis J.
Publicado: (2021)

Selective Use of Pulmonary Vasodilators in Patients with Fontan Physiology
por: Glenn, Thomas, et al.
Publicado: (2022)

Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness
por: Muzevich, Katie M, et al.
Publicado: (2014)

Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre−/PostCapillary Pulmonary Hypertension
por: Allen, Betty J., et al.
Publicado: (2023)

GIP-induced vasodilation in human adipose tissue involves capillary recruitment
por: Asmar, Meena, et al.
Publicado: (2019)

Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension
por: Tanaka, Mariko, et al.
Publicado: (2017)

Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension
por: Ghio, Stefano, et al.
Publicado: (2017)

Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report
por: L, Chomette, et al.
Publicado: (2021)

Dramatic and sustained responsiveness of pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension to vasodilator therapy
por: May, Adam, et al.
Publicado: (2014)

Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs()
por: Takahama, Hiroko, et al.
Publicado: (2019)

Pulmonary Vasodilator Therapy in Children with Single Ventricle Physiology: Effects on Saturation and Pulmonary Arterial Pressure
por: Jeremiasen, Ida, et al.
Publicado: (2020)

Alterations of pulmonary vascular afterload in exercise‐induced pre‐ and post‐capillary pulmonary hypertension
por: Karvasarski, Elizabeth, et al.
Publicado: (2023)

Pulmonary capillary hemangiomatosis: an uncommon cause of pulmonary hypertension
por: Faria, Igor Murad, et al.
Publicado: (2013)

Correction: Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension
por: Ghio, Stefano, et al.
Publicado: (2018)

Transition from post‐capillary pulmonary hypertension to combined pre‐ and post‐capillary pulmonary hypertension in swine: a key role for endothelin
por: van Duin, Richard W. B., et al.
Publicado: (2018)

Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2015)

Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
por: Jain, Pritesh P, et al.
Publicado: (2014)

Acute vasodilator testing: An opportunity to advance the precision care of pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia
por: Jeremiasen, Ida, et al.
Publicado: (2022)

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease
por: Gillmeyer, Kari R., et al.
Publicado: (2021)

Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
por: Andersen, Asger, et al.
Publicado: (2021)

Pulmonary Tumor Thrombotic Microangiopathy with Administration of Pulmonary Vasodilator Resulting in Clinical Improvement Prior to Final Diagnosis
por: Tomioka, Tomoko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_br54sbvlimvkheklvbiudelnql